External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study

Saif Al-Shamsi, Romona Devi Govender, Jeffrey King, Saif Al-Shamsi, Romona Devi Govender, Jeffrey King

Abstract

Objectives: Cardiovascular disease (CVD) risk prediction models are useful tools for identifying those at high risk of cardiovascular events in a population. No studies have evaluated the performance of such risk models in an Arab population. Therefore, in this study, the accuracy and clinical usefulness of two commonly used Framingham-based risk models and the 2013 Pooled Cohort Risk Equation (PCE) were assessed in a United Arab Emirates (UAE) national population.

Design: A 10-year retrospective cohort study.

Setting: Outpatient clinics at a tertiary care hospital, Al-Ain, UAE.

Participants: The study cohort included 1041 UAE nationals aged 30-79 who had no history of CVD at baseline. Patients were followed until 31 December 2019. Eligible patients were grouped into the PCE and the Framingham validation cohorts.

Exposure: The 10-year predicted risk for CVD for each patient was calculated using the 2008 Framingham risk model, the 2008 office-based Framingham risk model, and the 2013 PCE model.

Primary outcome measure: The discrimination, calibration and clinical usefulness of the three models for predicting 10-year cardiovascular risk were assessed.

Results: In women, the 2013 PCE model showed marginally better discrimination (C-statistic: 0.77) than the 2008 Framingham models (C-statistic: 0.74-0.75), whereas all three models showed moderate discrimination in men (C-statistic: 0.69‒0.70). All three models overestimated CVD risk in both men and women, with higher levels of predicted risk. The 2008 Framingham risk model (high-risk threshold of 20%) classified only 46% of women who subsequently developed incident CVD within 10 years as high risk. The 2013 PCE risk model (high-risk threshold of 7.5%) classified 74% of men who did not develop a cardiovascular event as high risk.

Conclusions: None of the three models is accurate for predicting cardiovascular risk in UAE nationals. The performance of the models could potentially be improved by recalibration.

Keywords: cardiovascular disease; framingham; pooled cohort equation; risk prediction; united arab emirates; validation.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow chart of patients included in the study. ASCVD, atherosclerotic cardiovascular disease; CVD, cardiovascular disease; PCE, Pooled Cohort Risk Equation.
Figure 2
Figure 2
Calibration plots of observed and predicted 10-year cardiovascular disease risks using the 2008 Framingham (green), 2008 office-based Framingham (red), and PCE (black) risk prediction models in Emirati men and women. PCE, Pooled Cohort Risk Equation.

References

    1. Roth GA, Abate D, Abate KH, et al. . Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. The Lancet 2018;392:1736–88. 10.1016/S0140-6736(18)32203-7
    1. Benjamin EJ, Virani SS, Callaway CW, et al. . Heart disease and stroke Statistics—2018 update: a report from the American heart association. Circulation 2018;137 10.1161/CIR.0000000000000558
    1. Loney T, Aw T-C, Handysides DG, et al. . An analysis of the health status of the United Arab Emirates: the 'Big 4' public health issues. Glob Health Action 2013;6:20100. 10.3402/gha.v6i0.20100
    1. Karmali KN, Persell SD, Perel P, et al. . Risk scoring for the primary prevention of cardiovascular disease. Cochrane heart group. Cochrane Database Syst Rev 2020.
    1. D'Agostino RB, Pencina MJ, Massaro JM, et al. . Cardiovascular disease risk assessment: insights from Framingham. Glob Heart 2013;8:11–23. 10.1016/j.gheart.2013.01.001
    1. Hajat C, Harrison O. The abu dhabi cardiovascular program: the continuation of Framingham. Prog Cardiovasc Dis 2010;53:28–38. 10.1016/j.pcad.2010.05.002
    1. Alzubaidi HT, Chandir S, Hasan S, et al. . Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study. BMJ Open 2019;9:e031246 10.1136/bmjopen-2019-031246
    1. Al Sayed N, Al Waili K, Alawadi F, et al. . Consensus clinical recommendations for the management of plasma lipid disorders in the middle East. Int J Cardiol 2016;225:268–83. 10.1016/j.ijcard.2016.09.081
    1. D'Agostino RB, Vasan RS, Pencina MJ, et al. . General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008;117:743–53. 10.1161/CIRCULATIONAHA.107.699579
    1. Goff DC, Lloyd-Jones DM, Bennett G, et al. . ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American heart association Task force on practice guidelines. Circulation 2013;2014:S49–73.
    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62–9. 10.2337/dc10-S062
    1. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361–87. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>;2-4
    1. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565–74. 10.1177/0272989X06295361
    1. Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making 2015;35:162–9. 10.1177/0272989X14547233
    1. DeFilippis AP, Young R, Carrubba CJ, et al. . An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med 2015;162:266 10.7326/M14-1281
    1. Hua X, McDermott R, Lung T, et al. . Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort. Eur J Prev Cardiol 2017;24:1660–9. 10.1177/2047487317722913
    1. Chia YC, Gray SYW, Ching SM, et al. . Validation of the Framingham General cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open 2015;5:e007324. 10.1136/bmjopen-2014-007324
    1. Chia YC, Lim HM, Ching SM. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study. BMC Cardiovasc Disord 2014;14:163. 10.1186/1471-2261-14-163
    1. Wallisch C, Heinze G, Rinner C, et al. . External validation of two Framingham cardiovascular risk equations and the pooled cohort equations: a nationwide registry analysis. Int J Cardiol 2019;283:165–70. 10.1016/j.ijcard.2018.11.001
    1. Albarqouni L, Doust JA, Magliano D, et al. . External validation and comparison of four cardiovascular risk prediction models with data from the Australian diabetes, obesity and lifestyle study. Med J Aust 2019;210:161–7. 10.5694/mja2.12061
    1. Rabanal KS, Meyer HE, Pylypchuk R, et al. . Performance of a Framingham cardiovascular risk model among Indians and Europeans in New Zealand and the role of body mass index and social deprivation. Open Heart 2018;5:e000821. 10.1136/openhrt-2018-000821
    1. Rana JS, Tabada GH, Solomon MD, et al. . Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol 2016;67:2118–30. 10.1016/j.jacc.2016.02.055
    1. Hajar R. Statins: past and present. Heart Views 2011;12:121. 10.4103/1995-705X.95070
    1. Cook NR, Ridker PM. Further insight into the cardiovascular risk calculator: The roles of statins, revascularizations, and underascertainment in the women’s health study. JAMA Intern Med 1964;2014:174.
    1. Al-Shamsi S, Regmi D, Govender RD. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study. BMC Cardiovasc Disord 2019;19:148. 10.1186/s12872-019-1131-2
    1. al-Rajeh S, Larbi EB, Bademosi O, et al. . Stroke register: experience from the eastern Province of Saudi Arabia. Cerebrovasc Dis 1998;8:86–9. 10.1159/000015823
    1. Akhtar N, Kamran SI, Deleu D, et al. . Ischaemic posterior circulation stroke in state of Qatar. Eur J Neurol 2009;16:1004–9. 10.1111/j.1468-1331.2009.02709.x
    1. Gehani AA, Al-Hinai AT, Zubaid M, et al. . Association of risk factors with acute myocardial infarction in middle Eastern countries: the INTERHEART middle East study. Eur J Prev Cardiol 2014;21:400–10. 10.1177/2047487312465525
    1. Zubaid M, Rashed WA, Al-Khaja N, et al. . Clinical presentation and outcomes of acute coronary syndromes in the Gulf registry of acute coronary events (Gulf race). Saudi Med J 2008;29:251–5.
    1. Hajat C, Harrison O, Al Siksek Z. Weqaya: a population-wide cardiovascular screening program in abu dhabi, United Arab Emirates. Am J Public Health 2012;102:909–14. 10.2105/AJPH.2011.300290

Source: PubMed

3
Subskrybuj